Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancerTetsuaki Shoji(Hokkaido University), Satoshi Konno(Hokkaido University)Cancer Chemotherapy and PharmacologyMarch 30, 202010.1007/s00280-020-04061-9Cited by 16SaveCiteExport RISWatch citationsRelated PapersFamilial multifocal micronodular pneumocyte hyperplasia with a novel splicing mutation in TSC1: Three cases in one family|PLoS ONE|2019|8Inhibition of non-homologous end joining mitigates paclitaxel resistance resulting from mitotic slippage in non-small cell lung cancer|Cell Cycle|2023|1